Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_01-cv-02214/USCOURTS-cand-3_01-cv-02214-6/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 35:271 Patent Infringement

---

United States District Court

For the Northern District of California

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

United States District Court

For the Northern District of California

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF CALIFORNIA

SYNTEX (U.S.A.) LLC, a Delaware corporation;

ALLERGAN, INC., a Delaware corporation,

Plaintiffs,

 v.

APOTEX INC., a Canadian corporation;

APOTEX CORP., a Delaware corporation; and

NOVEX PHARMA, a Canadian corporation.

Defendants. /

No. C 01-02214 MJJ

Related case:

No. C 05-02116 MJJ

ORDER RE SUPPLEMENTAL

BRIEFING

On February 23, 2006, the Court held a hearing on Plaintiffs’ Request for Preliminary Injunctive

Relief and on Defendants’ obviousness challenge. In reviewing the docket record, it does not appear

that the parties filed proposed findings of fact and conclusions of law either before or after the hearing.

Accordingly, the Court directs the parties to file proposed findings of fact and conclusions of law,

including citations to the evidentiary record, when applicable, by 8:00 a.m., on Monday, March 20,

2006. Additionally, the parties shall submit to the Court a copy of their proposed findings of fact and

conclusions of law on disk, in Wordperfect 10 format. 

IT IS SO ORDERED.

Dated: March 14, 2006 

MARTIN J. JENKINS

UNITED STATES DISTRICT JUDGE

Case 3:01-cv-02214-MJJ Document 481 Filed 03/14/06 Page 1 of 1